Delivery Order SPE2DB22D1017-SPE2DB25FG8FQ
- Not listed
- This is a $1,508.70 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EVOXAC 30 MG CAPSULE 100S, a prescription medication, with a completion date of January 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a $311,880 delivery order to AmerisourceBergen Drug Corporation for 100 capsules of 30mg Cevimeline hydrochloride to be delivered to its Conshohocken, Pennsylvania facility by July 25, 2023. The firm fixed price order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. No subcontractors or set aside designations were specified. The Defense Logistics...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,306.92 firm fixed-price delivery order is for the supply of 4560488341 - Cevimeline HCL 30 mg capsules, a prescription medication. The contract has an ultimate completion date of April 5, 2023 and was awarded on April 4, 2023. AmerisourceBergen, a for-profit organization, is the prime contractor and does not have any set-aside designation. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for EOHILIA 2 mg/10 ml stick pack pharmaceutical product on July 25, 2025, with a ceiling value of $1,260.98. This firm fixed price delivery order, with an ultimate completion date of July 28, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a $4,673.47 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eohilia 2 mg/10 ml stick pack medication. The contract represents a firm fixed-price delivery order with a completion date of July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product. This firm fixed-price delivery order, valued at $1,223.59, represents a competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to the federal government. The contract, valued at $5,766.06, is for the supply of 4565403683 EOHILIA 2 MG/10 ML STICK PACK 10ML, a pharmaceutical product. The contract does not have a set-aside designation and is a firm fixed-price delivery order with an ultimate completion date of August 12, 2024. Amerisourcebergen...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36,000 units of a pharmaceutical capsule product, with a ceiling value of $3,386.08 and an ultimate completion date of July 14, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,670.77 to AmerisourceBergen Drug Corp on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order is for XDEMVY 0.25% DROP 10ML pharmaceutical product and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. The award involved no set-aside designation and was competitively awarded to the vendor. This...
- This is a $6,335.36 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 4565377855 EOHILIA 2 MG/10 ML STICK PACK 10ML, a pharmaceutical product. The award date is August 7, 2024, with an ultimate completion date of August 8, 2024. This delivery order contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8FQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Evoxac 30 mg, a pharmaceutical product used to treat dry mouth associated with Sjögren's syndrome. The contract, with a ceiling value of $2,752.58, was competitively awarded on July 25, 2025, with an ultimate completion date of July 28, 2025. This delivery order falls under a firm fixed-price arrangement with no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military healthcare programs worldwide through this prime vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/25/25 |